Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to carry out the additional assessment for „Chitin-glucan‟ as a food ingredient in the context of Regulation (EC) No. 258/97. The Novel Food ingredient called “KiOnutrime-CG™” has a content of more than 90 % chitin-glucan, which is the main component in the cell walls of the mycelium of Aspergillus niger derived from a fermentation process. The compositional data and the manufacturing process do not give rise to concerns. The ingredient is intended to be marketed as a food supplement to increase the daily intake of fibre. The intended intake of chitin-glucan is 2 to 5 g/day. At the highest dose administered in a 13-week rat study, i.e. about 6.6 g/kg body weight (bw), no adverse effects were observed. This dose is approximately 80-fold higher than the maximum intended level of intake for humans on a g/kg bw basis. The Panel concludes that Novel Food KiOnutrime-CG™ is safe as a food ingredient at the proposed conditions of use and the proposed intake levels
Scientific Opinion on the safety of ‘Chitin-glucan’ as a Novel Food ingredient / C.V. Agostoni, J.L. Bresson, S. Fairweather Tait, A. Flynn, I. Golly, H. Korhonen, P. Lagiou, M. Løvik, R. Marchelli, A. Martin, B. Moseley, M. Neuhäuser Berthold, H. Przyrembel, S. Salminen, Y. Sanz, S. Strain, S. Strobel, I. Tetens, D. Tomé, H. van Loveren, H. Verhagen. - In: EFSA JOURNAL. - ISSN 1831-4732. - 8:7(2010). [10.2903/j.efsa.2010.1687]
Scientific Opinion on the safety of ‘Chitin-glucan’ as a Novel Food ingredient
C.V. AgostoniPrimo
;
2010
Abstract
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to carry out the additional assessment for „Chitin-glucan‟ as a food ingredient in the context of Regulation (EC) No. 258/97. The Novel Food ingredient called “KiOnutrime-CG™” has a content of more than 90 % chitin-glucan, which is the main component in the cell walls of the mycelium of Aspergillus niger derived from a fermentation process. The compositional data and the manufacturing process do not give rise to concerns. The ingredient is intended to be marketed as a food supplement to increase the daily intake of fibre. The intended intake of chitin-glucan is 2 to 5 g/day. At the highest dose administered in a 13-week rat study, i.e. about 6.6 g/kg body weight (bw), no adverse effects were observed. This dose is approximately 80-fold higher than the maximum intended level of intake for humans on a g/kg bw basis. The Panel concludes that Novel Food KiOnutrime-CG™ is safe as a food ingredient at the proposed conditions of use and the proposed intake levelsPubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.